glp-1 without diabetes Taking GLP‑1 in 2026: What Real People Notice After 3, 6 and 12 Months GLP-1 receptor agonism: a transformative

In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort

There is also a growing body of discussion around people using GLP-1 medications to maintain a normal weight after previous weight loss

GLP-1 receptors (GLP1R), which are found in pancreatic beta cells as well as other cell types, receive the GLP-1 signal, triggering the release of insulin

therefore, the comparative effects were generated with indirect evidence, and caution must be exercised when interpreting data from indirect comparison of CVOTs